According to Aurobindo Pharma 's latest financial reports the company's total assets are $5.28 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-03-31 | $4.85 B | 8.61% |
2022-03-31 | $4.47 B | -2.95% |
2021-03-31 | $4.60 B | 20.14% |
2020-03-31 | $3.83 B | 0.69% |
2019-03-31 | $3.81 B | 17.56% |
2018-03-31 | $3.24 B | 29.23% |
2017-03-31 | $2.50 B | 4.55% |
2016-03-31 | $2.39 B | 17.03% |
2015-03-31 | $2.04 B | 29.25% |
2014-03-31 | $1.58 B | 18.35% |
2013-03-31 | $1.33 B | 9.27% |
2012-03-31 | $1.22 B | -6.85% |
2011-03-31 | $1.31 B | 23.08% |
2010-03-31 | $1.06 B | 28.51% |
2009-03-31 | $0.83 B | -8.66% |
2008-03-31 | $0.91 B | 12.19% |
2007-03-31 | $0.81 B | 34.47% |
2006-03-31 | $0.60 B | 23.68% |
2005-03-31 | $0.48 B | 13.42% |
2004-03-31 | $0.43 B |